Clinical Trial Update: Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition [Phase 3]

View source ↗

Summary

A Phase 3 trial of gabapentin for functional dyspepsia refractory to proton pump inhibition has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: 59th Medical Wing | Conditions: Functional Dyspepsia | Phase 3 | Status: WITHDRAWN